3. Salewski RP, Mitchell RA, Shen C, et al. Transplantation of neural stem cells clonally derived from embryonic stem cells promotes recovery after murine spinal cord injury. Stem Cells Dev, 2015, 24(1): 36-50.
[3]
4. Steward O, Sharp K, Yee KM, et al. A re-assessment of the effects of a Nogo-66 receptor antagonist on regenerative growth of axons and locomotor recovery after spinal cord injury in mice. Exp Neurol, 2008, 209(2): 446-468.
[4]
5. Zahir T, Chen YF, MacDonald JF, et al. Neural stem/progenitor cells differentiate in vitro to neurons by the combined action of dibutyryl cAMP and interferon-gamma. Stem Cells Dev, 2009, 18(10): 1423-1432.
[5]
6. Atalay B, Bavbek M, Ozen O, et al. Nogo-A inhibitory peptide (NEP1-40) increases pan-cadherin expression following mild cortical contusion injury in rats. Turk Neurosurg, 2008, 18(4): 356-365.
[6]
7. Duricki DA, Huston TH, Kathe C, et al. Delayed intramuscular human neurotrophin-3improves recovery in adult and elderly rats after stroke. Brain, 2016, 139(Pt 1): 259-275.
[7]
8. Lu HX, Hao ZM, Jiao Q, et al. Neurotrophin-3 gene transduction of mouse neural stem cells promotes proliferation and neuronal differentiation in organotypic hippocampal slice cultures. Med Sci Monit, 2011, 17(11): 305-311.
10. Corti S, Locatelli F, Papadimitriou D, et al. Somatic stem cell research for neural repair: current evidence and emerging perspectives. J Cell Mol Med, 2004, 8(3): 329-337.
[10]
11. Hou T, Shi Y, Cheng SG, et al. Nogo-A expresses on neural stem cell surface. Int J Neurosci, 2010, 120(3): 201-205.
[11]
12. Steward O, Sharp K, Yee KM, et al. A re-assessment of the effects of a Nogo-66 receptor antagonist on regenerative growth of axons and locomotor recovery after spinal cord injury in mice. Exp Neurol, 2008, 209(2): 446-468.
[12]
15. Gou X, Wang Q, Yang Q, et al. TAT-NEP1-40 as a novel therapeutic candidate for axonal regeneration and functional recovery after stroke. J Drug Target, 2010, 19(2): 86-95.
23. Zhang L, Gu S, Zhao C, et al. Combined treatment of neurotrophin-3 gene and neural stem cells is propitious to functional recovery after spinal cord injury. Cell Transplant, 2007, 16(5): 475-481.
[17]
1. Kabatas S, Teng YD. Potential roles of the neural stem cell in the restoration of the injured spinal cord: review of the literature. Turk Neurosurg, 2010, 20(2): 103-110.
[18]
2. Cai PQ, Sun GY, Cai PS, et al. Survival of transplanted neurotrophin-3 expressing human neural stem cells and motor function in a rat model of spinal cord injury. Neural Regen Res, 2009, 4(7): 485-491.
[19]
13. Dupuis L, Pehar M, Cassina P, et al. Nogo receptor antagonizes p75NTR-dependent motor neuron death. Proc Natl Acad Sci U S A, 2008, 105(2): 740-745.
[20]
14. Atalay B, Bavbek M, Cekinmez M, et al. Antibodies neutralizing Nogo-A increase pan-cadherin expression and motor recovery following spinal cord injury in rats. Spinal Cord, 2007, 45(12): 780-786.
19. Abu El-Asrar AM, Mohammad G, De Hertogh G, et al. Neurotrophins and neurotrophin receptors in proliferative diabetic retinopathy. PLoS One, 2013, 8(6): e654-672.
[23]
21. Bambakidis NC, Miller RH. Transplantation of oligodendrocyte precursors and sonic hedgehog results in improved function and white matter sparing in the spinal cords of adult rats after contusion. Spine J, 2004, 4(1): 16-26.
